A saliva-reactive inner film releases fluoride ions inside shell retainers to suppress bacteria and support enamel remineralization.
Combines Compound I or its deuterated derivative with CFTR modulators to improve ion transport and address mucus accumulation.
Separate granules prevent simethicone from hindering compressibility, ensuring more than 85% of otilonium bromide releases within 15 minutes.
Formula I compounds stabilize the CFTR protein structure to correct misfolding and restore respiratory function in cystic fibrosis patients.
Organosilane compositions form dry residual antimicrobial coatings on medical dressings without oily residues.
Combines CDK4/6 and topoisomerase I inhibitors to treat Rb-negative tumors while reducing secondary malignancy risks.
A chewable effervescent dosage form delivers rapid gastrointestinal relief through controlled oral gas generation.